Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001567619-21-000896
Filing Date
2021-01-12
Accepted
2021-01-12 10:33:35
Documents
1
Effectiveness Date
2021-01-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12483
  Complete submission text file 0001567619-21-000896.txt   13506
Mailing Address 228 PARK AVENUE SOUTH NEW YORK NY 10003
Business Address 228 PARK AVENUE SOUTH NEW YORK NY 10003 805-691-9355
Elucida Oncology, Inc. (Filer) CIK: 0001704594 (see all company filings)

EIN.: 471358366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-380142 | Film No.: 21522682